{
  "report_header": {
    "analysis_date": "2026-02-01",
    "stock_code": "032830",
    "stock_name": "삼성생명"
  },
  "investment_summary": {
    "rating": "SELL",
    "target_price": 168000,
    "current_price": 188300,
    "upside_pct": -10.8,
    "conviction_score": 47.0
  },
  "agent_scores": [
    {
      "agent": "Financial Agent",
      "score": 50,
      "weight": 0.25,
      "weighted_score": 12.5,
      "rationale": "재무 데이터 없음 - 기본값 적용"
    },
    {
      "agent": "Valuation Agent",
      "score": 25.0,
      "weight": 0.2,
      "weighted_score": 5.0,
      "rationale": "고평가 (목표가: 168,000원, 상승여력: -10.8%)"
    },
    {
      "agent": "Technical Agent",
      "score": 40,
      "weight": 0.15,
      "weighted_score": 6.0,
      "rationale": "등락률: -1.93%"
    },
    {
      "agent": "Industry Agent",
      "score": 60,
      "weight": 0.15,
      "weighted_score": 9.0,
      "rationale": "업종 분석 - 기본값 적용"
    },
    {
      "agent": "Risk Agent",
      "score": 60,
      "weight": 0.15,
      "weighted_score": 9.0,
      "rationale": "위험 평가 기반"
    },
    {
      "agent": "Sentiment Agent",
      "score": 55,
      "weight": 0.1,
      "weighted_score": 5.5,
      "rationale": "심리 분석 - 기본값 적용"
    }
  ],
  "valuation": {
    "per": 16.05,
    "pbr": 1.1,
    "target_price": 168000
  },
  "risk_assessment": {
    "level": "LOW",
    "factors": []
  },
  "summary": "삼성생명(032830)에 대해 SELL 의견을 제시합니다. Conviction Score 47.0/100으로 목표가 168,000원(상승여력 -10.8%)을 설정했습니다."
}